Form D · Biotechnology
NONO, Inc.
Toronto, A6 · CIK 0001571723
Offering snapshot reported May 24, 2013 · SEC filing
- Reported sold
- $9.78M Offering amount: $9.78M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 22, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2013 | Initial | $9,776,044 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-197046
All currency amounts are in Canadian dollars.
Source: Form D, filed May 24, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Josephson | Director |
| Mark Krembil | Director |
| Michael Salter | Director, Executive |
| Michael Tymianski | Director, Executive |
| Gregory Wolfond | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 W435 399 Bathurst Street
Toronto, A6, M5T 2S8
Toronto, A6, M5T 2S8